CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 849938-850369 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T1581","span":{"begin":0,"end":130},"obj":"Sentence"},{"id":"T20446","span":{"begin":131,"end":147},"obj":"Sentence"},{"id":"T26540","span":{"begin":148,"end":164},"obj":"Sentence"},{"id":"T7106","span":{"begin":165,"end":184},"obj":"Sentence"},{"id":"T24969","span":{"begin":185,"end":201},"obj":"Sentence"},{"id":"T23779","span":{"begin":202,"end":213},"obj":"Sentence"},{"id":"T83722","span":{"begin":214,"end":230},"obj":"Sentence"},{"id":"T14217","span":{"begin":231,"end":246},"obj":"Sentence"},{"id":"T99716","span":{"begin":247,"end":431},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Expression of novel B7 molecules by human glioma cells in vitro and in vivo: B7-H1 as a potential mechanism of immune paralysis S. Wintterle a , B. Schreiner a , M. Mitsdoerffer a , D. Schneider a , L. Chen b , R. Meyermann a , M. Weller a and H. Wiendl a a University of Tübingen,Tübingen, Germany; b Mayo Clinic, Rochester, MN, USA Human glioblastoma is a highly lethal tumor that is known for its immune inhibitory capabilities."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T1701","span":{"begin":0,"end":431},"obj":"Epistemic_statement"}],"text":"Expression of novel B7 molecules by human glioma cells in vitro and in vivo: B7-H1 as a potential mechanism of immune paralysis S. Wintterle a , B. Schreiner a , M. Mitsdoerffer a , D. Schneider a , L. Chen b , R. Meyermann a , M. Weller a and H. Wiendl a a University of Tübingen,Tübingen, Germany; b Mayo Clinic, Rochester, MN, USA Human glioblastoma is a highly lethal tumor that is known for its immune inhibitory capabilities."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T311","span":{"begin":0,"end":130},"obj":"Sentence"},{"id":"T312","span":{"begin":131,"end":147},"obj":"Sentence"},{"id":"T313","span":{"begin":148,"end":164},"obj":"Sentence"},{"id":"T314","span":{"begin":165,"end":184},"obj":"Sentence"},{"id":"T315","span":{"begin":185,"end":201},"obj":"Sentence"},{"id":"T316","span":{"begin":202,"end":213},"obj":"Sentence"},{"id":"T317","span":{"begin":214,"end":230},"obj":"Sentence"},{"id":"T318","span":{"begin":231,"end":246},"obj":"Sentence"},{"id":"T319","span":{"begin":247,"end":431},"obj":"Sentence"}],"text":"Expression of novel B7 molecules by human glioma cells in vitro and in vivo: B7-H1 as a potential mechanism of immune paralysis S. Wintterle a , B. Schreiner a , M. Mitsdoerffer a , D. Schneider a , L. Chen b , R. Meyermann a , M. Weller a and H. Wiendl a a University of Tübingen,Tübingen, Germany; b Mayo Clinic, Rochester, MN, USA Human glioblastoma is a highly lethal tumor that is known for its immune inhibitory capabilities."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T1733","span":{"begin":42,"end":48},"obj":"Phenotype"},{"id":"T1734","span":{"begin":118,"end":127},"obj":"Phenotype"},{"id":"T1735","span":{"begin":340,"end":352},"obj":"Phenotype"},{"id":"T1736","span":{"begin":372,"end":377},"obj":"Phenotype"}],"attributes":[{"id":"A1733","pred":"hp_id","subj":"T1733","obj":"http://purl.obolibrary.org/obo/HP_0009733"},{"id":"A1734","pred":"hp_id","subj":"T1734","obj":"http://purl.obolibrary.org/obo/HP_0003470"},{"id":"A1735","pred":"hp_id","subj":"T1735","obj":"http://purl.obolibrary.org/obo/HP_0012174"},{"id":"A1736","pred":"hp_id","subj":"T1736","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Expression of novel B7 molecules by human glioma cells in vitro and in vivo: B7-H1 as a potential mechanism of immune paralysis S. Wintterle a , B. Schreiner a , M. Mitsdoerffer a , D. Schneider a , L. Chen b , R. Meyermann a , M. Weller a and H. Wiendl a a University of Tübingen,Tübingen, Germany; b Mayo Clinic, Rochester, MN, USA Human glioblastoma is a highly lethal tumor that is known for its immune inhibitory capabilities."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5225","span":{"begin":42,"end":48},"obj":"Disease"},{"id":"T5226","span":{"begin":340,"end":352},"obj":"Disease"},{"id":"T5228","span":{"begin":372,"end":377},"obj":"Disease"},{"id":"T44850","span":{"begin":42,"end":48},"obj":"Disease"},{"id":"T29415","span":{"begin":340,"end":352},"obj":"Disease"},{"id":"T72855","span":{"begin":372,"end":377},"obj":"Disease"}],"attributes":[{"id":"A5225","pred":"mondo_id","subj":"T5225","obj":"http://purl.obolibrary.org/obo/MONDO_0021042"},{"id":"A5226","pred":"mondo_id","subj":"T5226","obj":"http://purl.obolibrary.org/obo/MONDO_0018177"},{"id":"A5227","pred":"mondo_id","subj":"T5226","obj":"http://purl.obolibrary.org/obo/MONDO_0020690"},{"id":"A5228","pred":"mondo_id","subj":"T5228","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A80940","pred":"mondo_id","subj":"T44850","obj":"http://purl.obolibrary.org/obo/MONDO_0021042"},{"id":"A84881","pred":"mondo_id","subj":"T29415","obj":"http://purl.obolibrary.org/obo/MONDO_0018177"},{"id":"A50895","pred":"mondo_id","subj":"T29415","obj":"http://purl.obolibrary.org/obo/MONDO_0020690"},{"id":"A78500","pred":"mondo_id","subj":"T72855","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"Expression of novel B7 molecules by human glioma cells in vitro and in vivo: B7-H1 as a potential mechanism of immune paralysis S. Wintterle a , B. Schreiner a , M. Mitsdoerffer a , D. Schneider a , L. Chen b , R. Meyermann a , M. Weller a and H. Wiendl a a University of Tübingen,Tübingen, Germany; b Mayo Clinic, Rochester, MN, USA Human glioblastoma is a highly lethal tumor that is known for its immune inhibitory capabilities."}